PODD Insulet Corporation - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 5, 2026
$131.69
· of 52w range
· above low
· to high
$126.4052w low
$354.8852w high
Market Cap (MRQ)
$9.13B
P/E (TTM)
24.7
EPS (TTM)
$5.33
Revenue (TTM)
$3.05B
your badges
52W Range
$126–$355
Analyst Rating
HOLD
Price Target
$172
P/E
24.7
ROE
26.0%
Net Profit Margin
12.3%
Your badge strip is empty — pin a metric anywhere on this page.
PODD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$131.69
Market Cap (MRQ)
$9.13B
P/E (TTM)
24.7
EPS (TTM)
$5.33
Revenue (TTM)
$3.05B
ROE (TTM)
26.0%
Debt/Equity (MRQ)
0.0
52W Range
$126–$355
PODD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$2.71B2017-12-31 → 2025-12-31
EPS$3.482017-12-31 → 2025-12-31
Free Cash Flow$378M2017-12-31 → 2025-12-31
Net margin12.3%2017-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | PODD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 24.75Y avg ≈1103.0 | ≈1103.0 | 28.6 | Fair value | |
| P/S (TTM) | 3.05Y avg ≈11.5 | ≈11.5 | 3.3 | Fair value | |
| P/B (MRQ) | 6.45Y avg ≈25.0 | ≈25.0 | 2.9 | Overvalued | |
| Price / FCF (TTM) | 31.15Y avg ≈-1004.0 | ≈-1004.0 | · | · | |
| Price / Cash Flow (TTM) | 17.95Y avg ≈16.7 | ≈16.7 | 16.9 | Overvalued | |
| Price / Tangible Book (MRQ) | 7.05Y avg ≈31.0 | ≈31.0 | · | · | |
| PEG Ratio | ≈0.2 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | PODD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin (TTM) | 71.1%5Y avg ≈68.0% | ≈68.0% | 58.4% | Top tier | |
| Operating Margin (TTM) | 16.9%5Y avg ≈11.9% | ≈11.9% | 11.9% | Top tier | |
| EBITDA Margin (TTM) | 20.1%5Y avg ≈16.3% | ≈16.3% | 13.1% | Top tier | |
| Pretax Margin (TTM) | 16.2%5Y avg ≈8.5% | ≈8.5% | 10.9% | Top tier | |
| Net Profit Margin (TTM) | 12.3%5Y avg ≈8.7% | ≈8.7% | 8.1% | Top tier | |
| ROA (TTM) | 11.3%5Y avg ≈6.4% | ≈6.4% | 3.2% | Top tier | |
| ROE (TTM) | 26.0%5Y avg ≈17.5% | ≈17.5% | 5.8% | Top tier | |
| ROIC | 22.5%5Y avg ≈17.9% | ≈17.9% | 5.5% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | PODD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 0.05Y avg ≈1.1 | ≈1.1 | 0.6 | Low debt | |
| Current Ratio (MRQ) | 2.55Y avg ≈3.9 | ≈3.9 | 2.5 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | PODD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 30.7%5Y avg ≈24.6% | ≈24.6% | · | · | |
| Revenue CAGR 3Y | 27.5%5Y avg ≈24.8% | ≈24.8% | · | · | |
| Revenue CAGR 5Y | 24.5% | · | · | · | |
| EPS YoY | -39.8%5Y avg ≈845.2% | ≈845.2% | · | · | |
| Net Income YoY | -40.9%5Y avg ≈904.2% | ≈904.2% | · | · | |
| EPS CAGR 3Y | 267.7%5Y avg ≈221.7% | ≈221.7% | · | · | |
| EPS CAGR 5Y | 103.4% | · | · | · | |
| Net Income CAGR 3Y | 277.3%5Y avg ≈227.1% | ≈227.1% | · | · | |
| Net Income CAGR 5Y | 105.2% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | PODD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.95Y avg ≈0.7 | ≈0.7 | 0.5 | Top tier | |
| Inventory Turnover | 1.75Y avg ≈1.5 | ≈1.5 | 2.1 | Weak | |
| Revenue / Employee | ≈$501.5K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
14.6%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 5, 2026 | $1.66 | $1.48 | 12.2% |
| March 31, 2026 | $1.42 | $1.22 | 16.2% | |
| Dec. 31, 2025 | $1.55 | $1.48 | 4.5% | |
| Sept. 30, 2025 | $1.24 | $1.16 | 6.5% | |
| June 30, 2025 | $1.17 | $0.95 | 23.7% | |
| March 31, 2025 | $1.01 | $0.81 | 24.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.71B | $2.07B | $1.70B | $1.31B | $1.10B | $904M | $738M | $564M | · | $367M | $264M | |
| Cost of Revenue | $768M | $626M | $537M | $500M | $347M | $322M | $258M | $194M | · | $156M | $131M | |
| Gross Profit | $1.94B | $1.45B | $1.16B | $806M | $752M | $582M | $480M | $370M | · | $211M | $133M | |
| R&D Expense | $301M | $220M | $205M | $180M | $160M | $147M | $132M | $95M | · | $56M | $43M | |
| SG&A Expense | $1.17B | $917M | $735M | $588M | $466M | $384M | $298M | $248M | · | $72M | $60M | |
| Operating Expenses | · | · | · | · | · | · | $430M | $343M | · | $222M | $182M | |
| Operating Income | $474M | $309M | $220M | $38M | $126M | $52M | $50M | $27M | · | $-11M | $-49M | |
| Interest Expense | · | · | $36M | $36M | $62M | $48M | $35M | $29M | · | $14M | $13M | |
| Interest Income | $35M | $40M | $29M | $9M | $500.0K | $3M | $7M | $8M | · | · | · | |
| Other Non-op | $14M | $-6M | $2M | $-1M | $-2M | $3M | $900.0K | $-900.0K | · | $825.0K | $58.0K | |
| Pretax Income | $340M | $300M | $215M | $10M | $20M | $10M | $14M | $5M | · | $-27M | $-61M | |
| Income Tax | $92M | $-118M | $8M | $5M | $4M | $3M | $3M | $2M | · | $392.0K | $212.0K | |
| Net Income | $247M | $418M | $206M | $5M | $17M | $7M | $12M | $3M | · | $-29M | $-74M | |
| EPS (Basic) | $3.51 | $5.97 | $2.96 | $0.07 | $0.25 | $0.11 | $0.19 | $0.06 | · | $-0.48 | · | |
| EPS (Diluted) | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 | $0.10 | $0.19 | $0.05 | · | $-0.48 | · | |
| Shares (Basic) | 70,348,000 | 70,076,000 | 69,751,000 | 69,375,000 | 67,698,000 | 64,735,000 | 60,594,000 | 58,860,000 | · | 57,251,377 | · | |
| Shares (Diluted) | 71,886,000 | 73,891,000 | 73,633,000 | 69,910,000 | 68,579,000 | 65,946,000 | 62,304,000 | 61,008,000 | · | 57,251,377 | · | |
| EBITDA | $564M | $390M | $293M | $101M | $183M | $107M | $78M | · | · | $3M | $-45M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | $907M | $214M | $114M | · | $137M | $123M | |
| Short-term Investments | · | · | · | · | · | · | · | $175M | · | $161M | $0 | |
| Receivables | $517M | · | · | $141M | $135M | $95M | $69M | $63M | · | $29M | $43M | |
| Inventory | $453M | $430M | $403M | $347M | $303M | $154M | $101M | $71M | $33M | $36M | $12M | |
| Prepaid Expense | $228M | $142M | $116M | $87M | $74M | $52M | $45M | $24M | $16M | $7M | $4M | |
| Other Current Assets | · | $92M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $1.91B | $1.89B | $1.58B | $1.31B | $1.33B | $1.25B | $591M | $461M | $547M | $370M | $191M | |
| PP&E (Net) | · | · | · | $600M | $536M | $479M | $399M | $258M | · | $45M | $42M | |
| PP&E (Gross) | · | · | · | $835M | $716M | $607M | $490M | $324M | · | $84M | $70M | |
| Accum. Depreciation | · | · | · | $235M | $179M | $129M | $91M | $65M | · | $39M | $28M | |
| Goodwill | $52M | $52M | $52M | $52M | $40M | $40M | $40M | $40M | · | $40M | $40M | |
| Intangibles | $117M | $98M | $99M | $76M | $37M | $29M | $13M | $10M | · | $2M | $933.0K | |
| Other Non-current Assets | $288M | $182M | $188M | $210M | $106M | $77M | $41M | $2M | $15M | $216.0K | $76.0K | |
| Total Assets | $3.19B | $3.09B | $2.59B | $2.25B | $2.05B | $1.87B | $1.14B | $929M | $840M | $457M | $275M | |
| Accounts Payable | $75M | $20M | $19M | $31M | $38M | $54M | $54M | $26M | · | $13M | $15M | |
| Accrued Liabilities | $587M | · | · | $301M | $164M | $138M | $103M | $90M | · | $41M | $37M | |
| Current Liabilities | $680M | $528M | $451M | $365M | $229M | $208M | $158M | $116M | $89M | $56M | $65M | |
| Capital Leases | $49M | $40M | $30M | $27M | $8M | $12M | $14M | · | · | $0 | $269.0K | |
| Other Non-current Liabilities | $64M | $52M | $38M | $36M | $15M | $18M | $21M | $9M | $6M | $5M | $4M | |
| Total Liabilities | $1.68B | $1.88B | $1.86B | $1.77B | $1.49B | $1.27B | $1.07B | $717M | $661M | $393M | $241M | |
| Long-term Debt | · | · | · | $1.40B | $1.27B | $1.06B | $888M | $592M | · | $333M | $172M | |
| Total Debt | $18M | $84M | $49M | $1.40B | $1.27B | $1.06B | $888M | · | · | $333M | $172M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $57.0K | $57.0K | |
| Paid-in Capital | $1.27B | $1.18B | $1.10B | $1.04B | $1.21B | $1.26B | $749M | $898M | · | $744M | $686M | |
| Retained Earnings | $287M | $40M | $-378M | $-584M | $-650M | $-666M | $-672M | $-684M | $-687M | $-680M | $-652M | |
| Treasury Stock | $60M | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $12M | $-13M | $8M | $20M | $-2M | $6M | $-1M | $-3M | · | $-726.0K | $-654.0K | |
| Stockholders' Equity | $1.52B | $1.21B | $733M | $476M | $556M | $604M | $76M | $212M | $179M | $63M | $34M | |
| Liabilities + Equity | $3.19B | $3.09B | $2.59B | $2.25B | $2.05B | $1.87B | $1.14B | $929M | $840M | $457M | $275M | |
| Shares Outstanding | 70,391,000 | 70,196,000 | 69,907,000 | 69,511,000 | 69,179,000 | 66,017,000 | 62,685,000 | 59,189,000 | · | 57,457,967 | 56,954,830 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90M | $81M | $73M | $63M | $57M | $55M | $28M | $16M | · | $14M | $16M | |
| Stock-based Comp | $63M | $69M | $48M | $41M | $34M | $36M | $29M | $38M | · | $24M | $19M | |
| Deferred Tax | $62M | $-137M | $500.0K | $-900.0K | $1M | $-1M | $-700.0K | $-400.0K | · | $-199.0K | $-181.0K | |
| Amort. of Intangibles | $10M | $10M | $10M | $7M | $7M | $17M | $3M | $2M | · | $1M | $1M | |
| Restructuring | · | · | · | · | · | · | · | $1M | · | · | · | |
| Other Non-cash | $107M | $-1M | $-182M | $11M | $-178M | $-13M | $31M | · | · | $8M | $26M | |
| Operating Cash Flow | $569M | $430M | $146M | $119M | $-68M | $84M | $98M | $36M | · | $16M | $-13M | |
| CapEx | $192M | $125M | $76M | $123M | $112M | $129M | $164M | $157M | · | $22M | $11M | |
| Investing Cash Flow | $-223M | $-146M | $-119M | $-191M | $-83M | $14M | $-74M | $-184M | · | $-178M | $-15M | |
| Debt Issued | · | · | · | · | · | · | $780M | $0 | · | $334M | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $780M | · | · | $334M | $0 | |
| Stock Issued | · | · | · | $0 | $0 | $478M | $0 | $0 | · | $5M | $8M | |
| Stock Repurchased | $60M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-60M | · | · | $0 | $0 | $478M | · | · | · | $5M | $8M | |
| Financing Cash Flow | $-595M | $-28M | $-14M | $-40M | $41M | $606M | $74M | $-9M | · | $177M | $-371.0K | |
| Net Change in Cash | $-237M | $249M | $14M | $-117M | $-116M | $708M | $100M | $-159M | · | $15M | $-29M | |
| Taxes Paid | $38M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $378M | $305M | $70M | $-4M | $-180M | $-45M | $-65M | · | · | $-6M | $-23M | |
| Levered FCF | · | · | $35M | $-21M | $-231M | $-79M | $-93M | · | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.6% | 69.8% | 68.3% | 61.7% | 68.5% | 64.4% | 65.1% | · | · | 57.5% | 45.7% | |
| Operating Margin | 17.5% | 14.9% | 13.0% | 2.9% | 11.5% | 5.7% | 6.8% | · | · | -2.9% | -18.7% | |
| Net Margin | 9.1% | 20.2% | 12.2% | 0.35% | 1.5% | 0.75% | 1.6% | · | · | -7.9% | -22.7% | |
| Pretax Margin | 12.5% | 14.5% | 12.7% | 0.75% | 1.9% | 1.1% | 2.0% | · | · | -7.3% | -22.6% | |
| EBITDA Margin | 20.8% | 18.8% | 17.2% | 7.7% | 16.7% | 11.8% | 10.5% | · | · | 0.85% | -13.9% | |
| ROA | 7.9% | 14.7% | 8.5% | 0.21% | 0.86% | 0.45% | 1.1% | · | · | -7.9% | -25.7% | |
| ROE | 16.6% | 35.9% | 30.8% | 1.0% | 3.2% | 1.1% | 10.2% | · | · | -59.4% | -124.7% | |
| ROIC | 22.5% | 33.2% | 27.0% | 0.94% | 5.6% | 2.2% | 4.2% | · | · | -2.7% | -29.6% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 3.6 | 3.5 | 3.6 | 5.8 | 6.0 | 3.7 | · | · | 6.6 | 2.9 | |
| Quick Ratio | · | · | · | 0.4 | 0.7 | 4.8 | 1.8 | · | · | 5.9 | 2.6 | |
| Debt / Equity | 0.0 | 0.1 | 0.1 | 2.9 | 2.3 | 1.8 | 11.7 | · | · | 5.3 | 5.0 | |
| LT Debt / Equity | · | · | · | 2.9 | 2.2 | 1.7 | 11.7 | · | · | 5.3 | 5.0 | |
| Interest Coverage | · | · | 6.1 | 1.0 | 2.0 | 1.1 | 1.4 | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | · | · | 1.0 | 1.1 | |
| Inventory Turnover | 1.7 | 1.5 | 1.4 | 1.5 | 1.5 | 2.5 | 3.0 | · | · | 6.6 | 13.0 | |
| Receivables Turnover | · | · | · | 9.5 | 8.6 | 11.8 | 11.1 | · | · | 10.3 | 7.3 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.53 | $17.26 | $10.48 | $6.85 | $8.04 | $9.14 | $1.21 | · | · | $1.10 | $0.60 | |
| Revenue / Share | $37.67 | $28.04 | $23.05 | $18.67 | $16.02 | $13.71 | $11.85 | · | · | · | · | |
| Cash Flow / Share | $7.92 | $5.82 | $1.98 | $1.70 | $-0.99 | $1.27 | $1.58 | · | · | · | · | |
| Cash / Share | · | · | · | · | · | $13.74 | $3.41 | · | · | $2.39 | $2.16 | |
| EPS (TTM) | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 | $0.10 | $0.19 | $0.05 | · | $-0.48 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 30.7% | 22.1% | 30.0% | 18.8% | 21.5% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 23.5% | 23.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 24.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -39.8% | 96.6% | 4100.0% | -70.8% | 140.0% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 267.7% | 188.8% | 208.6% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 103.4% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -40.9% | 102.8% | 4384.8% | -72.6% | 147.1% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 277.3% | 192.0% | 211.9% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 105.2% | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.71B | $2.07B | $1.70B | $1.31B | $1.10B | $904M | $738M | $564M | · | $367M | $264M | |
| Net Income TTM | $247M | $418M | $206M | $5M | $17M | $7M | $12M | $3M | · | $-29M | $-74M | |
| Market Cap | $20.01B | $18.33B | $15.17B | $20.46B | $18.41B | $16.88B | $10.73B | · | · | $2.17B | $2.15B | |
| Enterprise Value | · | · | · | · | · | $17.03B | $11.41B | · | · | $2.20B | $2.20B | |
| P/E | 81.7 | 45.2 | 73.8 | 4205.6 | 1108.6 | 2556.3 | 901.1 | 1586.4 | · | -78.5 | · | |
| P/S | 7.4 | 8.8 | 8.9 | 15.7 | 16.8 | 18.7 | 14.5 | · | · | 5.9 | 8.2 | |
| P/B | 13.2 | 15.1 | 20.7 | 43.0 | 33.1 | 28.0 | 141.4 | · | · | 34.3 | 63.2 | |
| P / Tangible Book | 14.9 | 17.3 | 26.0 | 58.6 | 38.4 | 31.5 | · | · | · | · | · | |
| P / Cash Flow | 35.1 | 42.6 | 104.1 | 172.0 | -270.3 | 200.9 | 109.1 | · | · | 136.1 | -171.4 | |
| P / FCF | 53.0 | 60.0 | 216.4 | -5247.0 | -102.3 | -375.0 | -164.3 | · | · | -349.0 | -92.9 | |
| EV / EBITDA | · | · | · | · | · | 159.3 | 146.4 | · | · | 702.8 | -49.0 | |
| EV / FCF | · | · | · | · | · | -378.4 | -174.7 | · | · | -354.5 | -95.0 | |
| EV / Revenue | · | · | · | · | · | 18.8 | 15.5 | · | · | 6.0 | 8.3 | |
| Earnings Yield | 1.2% | 2.2% | 1.4% | 0.02% | 0.09% | 0.04% | 0.11% | 0.06% | · | -1.3% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $802M | $762M | $784M | $706M | $649M | $569M | $598M | $544M | $488M | $442M | $510M | $433M | $396M | $358M | $370M | $341M | |
| Cost of Revenue | $239M | $233M | $215M | $196M | $197M | $160M | $167M | $167M | $158M | $135M | $149M | $139M | $132M | $118M | $152M | $152M | |
| Gross Profit | $563M | $529M | $569M | $510M | $452M | $409M | $431M | $377M | $331M | $307M | $361M | $293M | $265M | $240M | $217M | $188M | |
| R&D Expense | $88M | $90M | $91M | $77M | $73M | $60M | $61M | $55M | $54M | $50M | $42M | $58M | $55M | $50M | $50M | $45M | |
| SG&A Expense | $345M | $317M | $332M | $315M | $258M | $261M | $261M | $234M | $222M | $200M | $213M | $181M | $179M | $163M | $144M | $140M | |
| Operating Income | $130M | $122M | $146M | $118M | $121M | $89M | $109M | $88M | $54M | $57M | $106M | $55M | $31M | $28M | $24M | $3M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $11M | · | $10M | $10M | $9M | · | $9M | |
| Interest Income | $4M | $5M | $6M | $9M | $10M | $10M | $10M | $10M | $9M | $9M | $6M | $9M | $7M | $6M | $6M | $2M | |
| Other Non-op | $-1M | $700.0K | $3M | $12M | $1M | $-2M | $400.0K | $-3M | $-2M | $-700.0K | $2M | $700.0K | $-200.0K | $-200.0K | $2M | $-2M | |
| Pretax Income | $119M | $113M | $140M | $123M | $28M | $48M | $111M | $83M | $51M | $55M | $108M | $54M | $28M | $25M | $22M | $-6M | |
| Income Tax | $24M | $22M | $39M | $35M | $6M | $13M | $11M | $5M | $-138M | $3M | $4M | $2M | $1M | $800.0K | $5M | $-500.0K | |
| Net Income | $95M | $91M | $102M | $88M | $22M | $35M | $101M | $78M | $189M | $52M | $103M | $52M | $27M | $24M | $17M | $-5M | |
| EPS (Basic) | $1.37 | $1.30 | $1.45 | $1.24 | $0.32 | $0.50 | $1.43 | $1.11 | $2.69 | $0.74 | $1.49 | $0.74 | $0.39 | $0.34 | $0.25 | $-0.08 | |
| EPS (Diluted) | $1.37 | $1.30 | $1.42 | $1.24 | $0.32 | $0.50 | $1.38 | $1.08 | $2.59 | $0.73 | $1.47 | $0.74 | $0.39 | $0.34 | $0.25 | $-0.08 | |
| Shares (Basic) | 69,298,000 | 69,986,000 | · | 70,367,000 | 70,389,000 | 70,272,000 | · | 70,123,000 | 70,062,000 | 69,957,000 | · | 69,823,000 | 69,741,000 | 69,583,000 | · | 69,418,000 | |
| Shares (Diluted) | 69,403,000 | 70,202,000 | · | 70,661,000 | 70,652,000 | 74,111,000 | · | 73,951,000 | 73,802,000 | 73,741,000 | · | 73,624,000 | 70,142,000 | 70,096,000 | · | 69,418,000 | |
| EBITDA | $130M | $148M | · | $118M | $121M | $110M | · | $88M | $55M | $76M | · | $55M | $31M | $45M | · | $3M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $589M | $545M | · | · | · | · | · | · | · | · | · | · | · | $160M | · | $153M | |
| Inventory | $485M | $462M | $453M | $446M | $447M | $441M | $430M | $445M | $431M | $431M | · | $411M | $411M | $386M | · | $328M | |
| Prepaid Expense | $241M | $222M | $228M | $73M | $267M | $202M | $142M | $138M | $148M | $116M | · | $105M | $100M | $106M | · | $78M | |
| Other Current Assets | · | · | · | $121M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $1.85B | $1.71B | $1.91B | $1.86B | $2.28B | $2.33B | $1.89B | $1.86B | $1.75B | $1.62B | · | $1.47B | $1.42B | $1.33B | · | $1.33B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | $602M | $597M | · | $553M | |
| Goodwill | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | |
| Intangibles | $115M | $115M | $117M | $105M | $102M | $100M | $98M | $100M | $98M | $98M | · | $100M | $100M | $100M | · | $54M | |
| Other Non-current Assets | $291M | $281M | $206M | $188M | $315M | $319M | $182M | $166M | $164M | $188M | · | $196M | $212M | $211M | · | $179M | |
| Total Assets | $3.17B | $2.99B | $3.19B | $3.03B | $3.47B | $3.52B | $3.09B | $3.03B | $2.88B | $2.62B | · | $2.47B | $2.39B | $2.29B | · | $2.17B | |
| Accounts Payable | $123M | $150M | $75M | $48M | $96M | $58M | $20M | $40M | $77M | $76M | · | $78M | $108M | $86M | · | $62M | |
| Accrued Liabilities | $602M | $519M | · | · | · | · | · | · | · | · | · | · | · | $264M | · | $242M | |
| Current Liabilities | $744M | $688M | $680M | $648M | $1.01B | $520M | $528M | $506M | $486M | $432M | · | $451M | $425M | $383M | · | $334M | |
| Capital Leases | · | · | $49M | · | · | · | $40M | · | · | · | · | $30M | · | · | · | · | |
| Other Non-current Liabilities | $69M | $68M | $64M | $63M | $57M | $54M | $52M | $45M | $37M | $38M | · | $38M | $38M | $34M | · | $24M | |
| Total Liabilities | $1.74B | $1.68B | $1.68B | $1.65B | $2.01B | $2.19B | $1.88B | $1.91B | $1.88B | $1.83B | · | $1.86B | $1.83B | $1.79B | · | $1.74B | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $1.40B | $1.40B | · | $1.41B | |
| Total Debt | $19M | $19M | · | $80M | $461M | $83M | · | $42M | $38M | $39M | · | $50M | $1.40B | $1.40B | · | $1.41B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $1.31B | $1.28B | $1.27B | $1.25B | $1.38B | $1.26B | $1.18B | $1.16B | $1.14B | $1.12B | · | $1.08B | $1.07B | $1.05B | · | $1.02B | |
| Retained Earnings | $474M | $378M | $287M | $186M | $98M | $76M | $40M | $-60M | $-138M | $-326M | · | $-481M | $-533M | $-560M | · | $-601M | |
| Treasury Stock | $364M | $363M | $60M | $60M | $31M | · | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $2M | $6M | $12M | $12M | $15M | $-6M | $-13M | $20M | $-4M | $-500.0K | · | $8M | $16M | $16M | · | $7M | |
| Stockholders' Equity | $1.42B | $1.30B | $1.52B | $1.38B | $1.46B | $1.33B | $1.21B | $1.12B | $998M | $791M | $733M | $608M | $554M | $503M | $476M | $428M | |
| Liabilities + Equity | $3.17B | $2.99B | $3.19B | $3.03B | $3.47B | $3.52B | $3.09B | $3.03B | $2.88B | $2.62B | · | $2.47B | $2.39B | $2.29B | · | $2.17B | |
| Shares Outstanding | 69,351,000 | 69,264,000 | 70,390,816 | 70,346,000 | 70,391,000 | 70,361,846 | 70,196,031 | 70,141,692 | 70,112,039 | 70,020,202 | 69,907,000 | 69,825,875 | 69,804,489 | 69,694,363 | 69,511,000 | 69,431,159 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $26M | $24M | $22M | $22M | $22M | $22M | $21M | $19M | $19M | $19M | $19M | $18M | $17M | $16M | $16M | |
| Stock-based Comp | $20M | $21M | $20M | $17M | $8M | $18M | $20M | $18M | $17M | $14M | $13M | $10M | $13M | $12M | $11M | $9M | |
| Amort. of Intangibles | · | · | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-cash | · | $-25M | · | · | · | $-12M | · | · | · | $3M | · | · | · | $-53M | · | · | |
| Operating Cash Flow | $88M | $114M | $183M | $126M | $196M | $64M | $148M | $99M | $87M | $88M | $45M | $56M | $44M | $500.0K | $51M | $57M | |
| CapEx | $32M | $24M | $135M | $26M | $19M | $12M | $54M | $27M | $22M | $22M | $29M | $20M | $16M | $10M | $64M | $31M | |
| Investing Cash Flow | $-37M | $-28M | $-153M | $-31M | $-23M | $-16M | $-68M | $-29M | $-25M | $-24M | $-32M | $-23M | $-23M | $-42M | $-88M | $-34M | |
| Stock Repurchased | $0 | $300M | $0 | $30M | $30M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-300M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $-320M | $-72M | $-457M | $-344M | $278M | $-21M | $8M | $9M | $-14M | $2M | $-7M | $3M | $-12M | $-14M | $-4M | |
| Net Change in Cash | $54M | $-236M | $-41M | $-364M | $-162M | $330M | $51M | $82M | $70M | $47M | $19M | $25M | $24M | $-54M | $-47M | $13M | |
| Free Cash Flow | · | $90M | · | · | · | $52M | · | · | · | $66M | · | · | · | $-10M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $55M | · | · | · | $-19M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.2% | 69.5% | · | 72.2% | 69.7% | 71.9% | · | 69.3% | 67.7% | 69.5% | · | 67.8% | 66.8% | 67.2% | · | 55.2% | |
| Operating Margin | 16.2% | 16.0% | · | 16.7% | 18.7% | 15.6% | · | 16.2% | 11.2% | 12.9% | · | 12.7% | 7.8% | 7.7% | · | 0.85% | |
| Net Margin | 11.8% | 12.0% | · | 12.4% | 3.5% | 6.2% | · | 14.2% | 38.6% | 11.7% | · | 12.0% | 6.9% | 6.7% | · | -1.5% | |
| Pretax Margin | 14.8% | 14.8% | · | 17.4% | 4.4% | 8.5% | · | 15.2% | 10.5% | 12.4% | · | 12.4% | 7.2% | 6.9% | · | -1.7% | |
| EBITDA Margin | 16.2% | 19.5% | · | 16.7% | 18.7% | 19.4% | · | 16.2% | 11.2% | 17.1% | · | 12.7% | 7.8% | 12.5% | · | 0.85% | |
| ROA | 2.9% | 2.8% | · | 2.9% | 0.71% | 1.1% | · | 2.8% | 7.2% | 2.1% | · | 2.2% | 1.2% | 1.1% | · | -0.25% | |
| ROE | 6.6% | 6.9% | · | 7.0% | 1.8% | 3.3% | · | 9.0% | 24.3% | 8.0% | · | 10.0% | 5.6% | 5.0% | · | -1.1% | |
| ROIC | 7.2% | 7.4% | · | 5.7% | 5.0% | 4.6% | · | 7.1% | 19.4% | 6.4% | · | 8.1% | 1.5% | 1.4% | · | 0.14% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.5 | · | 2.9 | 2.3 | 4.5 | · | 3.7 | 3.6 | 3.7 | · | 3.3 | 3.3 | 3.5 | · | 4.0 | |
| Quick Ratio | 0.8 | 0.8 | · | · | · | · | · | · | · | · | · | · | · | 0.4 | · | 0.5 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 2.5 | 2.8 | · | 3.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | 2.5 | 2.7 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.3 | · | 5.3 | 3.2 | 2.9 | · | 0.3 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.4 | 0.4 | 0.3 | · | 0.5 | |
| Receivables Turnover | 2.2 | 2.2 | · | · | · | · | · | · | · | · | · | · | · | 2.3 | · | 2.5 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $20.51 | $18.81 | · | $19.68 | $20.78 | $18.91 | · | $15.94 | $14.24 | $11.29 | · | $8.70 | $7.93 | $7.21 | · | $6.16 | |
| Revenue / Share | $11.55 | $10.85 | · | $10.00 | $9.19 | $7.68 | · | $7.35 | $6.62 | $5.99 | · | $5.88 | $5.65 | $5.11 | · | $4.91 | |
| Cash Flow / Share | · | $1.62 | · | · | · | $0.86 | · | · | · | $1.19 | · | · | · | $0.01 | · | · | |
| EPS (TTM) | $5.33 | $4.28 | · | $3.44 | $3.28 | $5.55 | · | $5.87 | $5.53 | $3.33 | · | $1.72 | $0.90 | $0.01 | · | $0.25 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.05B | $2.90B | · | $2.52B | $2.36B | $2.20B | · | $1.98B | $1.87B | $1.78B | · | $1.56B | $1.47B | $1.37B | · | $1.24B | |
| Net Income TTM | $375M | $303M | · | $246M | $236M | $402M | · | $421M | $395M | $234M | · | $120M | $63M | $600.0K | · | $17M | |
| Market Cap | $10.56B | $14.53B | · | $21.72B | $22.12B | $18.48B | · | $16.33B | $14.15B | $12.00B | · | $11.14B | $20.13B | $22.23B | · | $15.93B | |
| P/E | 28.6 | 49.0 | · | 89.7 | 95.8 | 47.3 | · | 39.7 | 36.5 | 51.5 | · | 92.7 | 320.4 | 31896.0 | · | 917.6 | |
| P/S | 3.5 | 5.0 | · | 8.6 | 9.4 | 8.4 | · | 8.2 | 7.6 | 6.7 | · | 7.2 | 13.7 | 16.2 | · | 12.8 | |
| P/B | 7.4 | 11.2 | · | 15.7 | 15.1 | 13.9 | · | 14.6 | 14.2 | 15.2 | · | 18.3 | 36.3 | 44.2 | · | 37.2 | |
| P / Tangible Book | 8.4 | 12.8 | · | 17.7 | 16.9 | 15.7 | · | 16.9 | 16.7 | 18.7 | · | 24.4 | 50.0 | 63.4 | · | 49.4 | |
| P / Cash Flow | · | 127.7 | · | · | · | 289.6 | · | · | · | 137.0 | · | · | · | 44459.4 | · | · | |
| Earnings Yield | 3.5% | 2.0% | · | 1.1% | 1.0% | 2.1% | · | 2.5% | 2.7% | 1.9% | · | 1.1% | 0.31% | 0.00% | · | 0.11% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $2.71B | $2.07B | $1.70B | $1.31B | $1.10B |
| Gross Margin % | 71.6% | 69.8% | 68.3% | 61.7% | 68.5% |
| Operating Margin % | 17.5% | 14.9% | 13.0% | 2.9% | 11.5% |
| Net Income | $247M | $418M | $206M | $5M | $17M |
| Diluted EPS | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | 0.1 | 0.1 | 2.9 | 2.3 |
| Current Ratio | 2.8 | 3.6 | 3.5 | 3.6 | 5.8 |
| Quick Ratio | · | · | · | 0.4 | 0.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $378M | $305M | $70M | $-4M | $-180M |
Institutional owners (13F) 785 filers · $13.1B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
785
Value held
$13.1B
New positions
95
Exited positions
133
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 95 (-5 vs prior Q) | 133 (+15 vs prior Q) | 326 (+8 vs prior Q) | 244 (-21 vs prior Q) | +2.5M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2,473,306,401 | 8,701,472 | 18.89% | Shares |
| BlackRock, Inc. | $1,018,581,758 | 6,690,192 | 7.78% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $688,981,949 | 4,525,333 | 5.26% | Shares |
| STATE STREET CORP | $486,827,749 | 3,197,555 | 3.72% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $468,310,647 | 3,075,932 | 3.58% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $373,794,275 | 2,455,135 | 2.86% | Shares |
| BAILLIE GIFFORD & CO | $310,942,153 | 2,042,313 | 2.38% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $303,968,212 | 2,003,861 | 2.32% | Shares |
| TWO SIGMA INVESTMENTS, LP | $289,843,502 | 1,903,734 | 2.21% | Shares |
| Invesco Ltd. | $258,010,608 | 1,694,651 | 1.97% | Shares |
| MORGAN STANLEY | $225,185,911 | 1,479,050 | 1.72% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $223,970,255 | 1,471,069 | 1.71% | Shares |
| Clearbridge Investments, LLC | $200,875,774 | 1,319,381 | 1.53% | Shares |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $166,895,612 | 795,347 | 1.27% | Shares |
| Soleus Capital Management, L.P. | $159,710,250 | 1,049,000 | 1.22% | Shares |
| NORGES BANK | $159,555,869 | 1,047,986 | 1.22% | Shares |
| JUPITER ASSET MANAGEMENT LTD | $156,313,705 | 1,026,691 | 1.19% | Shares |
| FMR LLC | $146,814,214 | 964,297 | 1.12% | Shares |
| MILLENNIUM MANAGEMENT LLC | $131,755,171 | 865,387 | 1.01% | Shares |
| FIL Ltd | $127,893,958 | 840,026 | 0.98% | Shares |
| GOLDMAN SACHS GROUP INC | $124,580,823 | 818,265 | 0.95% | Shares |
| CITADEL ADVISORS LLC | $121,304,578 | 796,746 | 0.93% | Shares |
| FEDERATED HERMES, INC. | $106,909,036 | 702,194 | 0.82% | Shares |
| Vestal Point Capital, LP | $102,007,500 | 670,000 | 0.78% | Shares |
| Qube Research & Technologies Ltd | $101,089,128 | 663,968 | 0.77% | Shares |
| NORTHERN TRUST CORP | $98,948,496 | 649,908 | 0.76% | Shares |
| NORDEA INVESTMENT MANAGEMENT AB | $95,186,432 | 618,174 | 0.73% | Shares |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $94,776,509 | 622,506 | 0.72% | Shares |
| JPMORGAN CHASE & CO | $94,387,914 | 595,123 | 0.72% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $91,025,860 | 597,871 | 0.70% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $83,386,262 | 547,577 | 0.64% | Shares |
| UBS Group AG | $82,676,317 | 543,030 | 0.63% | Shares |
| Man Group plc | $78,746,289 | 517,217 | 0.60% | Shares |
| Amundi | $77,319,766 | 507,847 | 0.59% | Shares |
| AMERIPRISE FINANCIAL INC | $77,111,303 | 506,374 | 0.59% | Shares |
| Alecta Tjanstepension Omsesidigt | $71,461,456 | 469,400 | 0.55% | Shares |
| Vinva Investment Management Ltd | $68,542,735 | 430,460 | 0.52% | Shares |
| D. E. Shaw & Co., Inc. | $64,937,670 | 426,520 | 0.50% | Shares |
| BANK OF AMERICA CORP /DE/ | $64,920,770 | 426,409 | 0.50% | Shares |
| Bank of New York Mellon Corp | $60,615,312 | 398,130 | 0.46% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $60,598,088 | 398,017 | 0.46% | Shares |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $55,989,000 | 367,746 | 0.43% | Shares |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $53,701,163 | 352,717 | 0.41% | Shares |
| Stephens Investment Management Group LLC | $51,421,981 | 337,747 | 0.39% | Shares |
| DEUTSCHE BANK AG\ | $51,152,957 | 335,980 | 0.39% | Shares |
| Quantinno Capital Management LP | $48,251,490 | 316,922 | 0.37% | Shares |
| Legal & General Group Plc | $47,418,567 | 311,452 | 0.36% | Shares |
| Nuveen, LLC | $44,125,248 | 289,821 | 0.34% | Shares |
| Aberdeen Group plc | $43,823,641 | 287,840 | 0.33% | Shares |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $41,668,085 | 273,682 | 0.32% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC, OrbiMed Capital GP II LLC, Samuel D. Isaly ×3 filings | April 10, 2008 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 78 insiders · 44 officers · 27 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Ashley Mcevoy | President and CEO | Aug. 21, 2026 P | 23,731 | 2 | 0 | $1,191,422 |
| James Hollingshead | Former President and CEO | April 28, 2025 F | 61,247 | 0 | 0 | $0 |
| SULLIVAN PATRICK J | CEO and Chairman of the Board | March 29, 2018 F | 322,752 | 0 | 0 | $0 |
| Duane Desisto | President and CEO | Sept. 2, 2014 M | 257,184 | 0 | 0 | $0 |
| Flavia Pease | EVP & CFO | Feb. 24, 2026 A | 19,159 | 0 | 0 | $0 |
| Ana Maria Chadwick | EVP, CFO & Treasurer | May 1, 2025 F | 14,263 | 0 | 0 | $0 |
| Wayde D. Mcmillan | EVP, CFO | July 3, 2023 S | 21,477 | 0 | 0 | $0 |
| Michael L Levitz | SVP and CFO | Feb. 27, 2019 S | 56,651 | 0 | 0 | $0 |
| Allison Dorval | Chief Financial Officer | April 1, 2015 F | 37,415 | 0 | 0 | $0 |
| Brian K Roberts | Chief Financial Officer | April 1, 2014 F | 120,050 | 0 | 0 | $0 |
| Eric Benjamin | EVP and COO | Feb. 27, 2026 F | 23,600 | 0 | 0 | $0 |
| William Patrick Ryan | Chief Operating Officer | May 5, 2015 P | 47,990 | 0 | 0 | $0 |
| Luis Malave | Chief Operating Officer | March 1, 2010 A | 195,857 | 0 | 0 | $0 |
| Lisa Blair Davis | SVP, Chief HR Officer | Aug. 1, 2026 F | 4,453 | 0 | 0 | $0 |
| Michael Panos | EVP and CCO | April 1, 2026 A | 2,782 | 0 | 0 | $0 |
| Prem Singh | SVP, Global Operations | Feb. 27, 2026 F | 6,891 | 0 | 0 | $0 |
| Laetitia Cousin | SVP, Reg, Quality & Compliance | Feb. 27, 2026 F | 5,674 | 0 | 0 | $0 |
| Lauren Budden | Group VP, CAO and Controller | Feb. 27, 2026 F | 8,526 | 0 | 0 | $0 |
| John W. Kapples | SVP and General Counsel | Feb. 27, 2026 F | 27,514 | 0 | 0 | $0 |
| Dan Manea | SVP, Chief HR Officer | June 13, 2025 S | 9,090 | 0 | 0 | $0 |
| Mark N Field | SVP & Chief Technology Officer | Feb. 28, 2025 F | 13,411 | 0 | 0 | $0 |
| Charles Alpuche | Advisor | March 14, 2023 M | 56,954 | 0 | 0 | $0 |
| Spears Michael P | Advisor | March 9, 2023 M | 13,645 | 0 | 0 | $0 |
| Bret Christensen | EVP and CCO | Feb. 28, 2023 A | 20,178 | 0 | 0 | $0 |
| David Colleran | SVP, Secretary and GC | April 2, 2019 M | 30,433 | 0 | 0 | $0 |
| Aiman Abdel-Malek | EVP & Chief Technology Officer | March 28, 2019 F | 19,687 | 0 | 0 | $0 |
| Bradley A Thomas | EVP Human Resources | March 29, 2018 F | 65,818 | 0 | 0 | $0 |
| Daniel J Levangie | EVP & President, Drug Delivery | April 30, 2016 F | 21,122 | 0 | 0 | $0 |
| Anthony R Diehl | Secretary and General Counsel | May 11, 2015 M | 40,854 | 0 | 0 | $0 |
| Peter Devlin | Chief Commercial Officer | June 9, 2014 S | 67,354 | 0 | 0 | $0 |
| Tracey Haas Wielinski | VP, Global Regulatory, CA, QA | March 6, 2014 M | 24,000 | 0 | 0 | $0 |
| Ruthann Depietro | Vice President of Quality | Sept. 4, 2012 M | 18,351 | 0 | 0 | $0 |
| Carsten Boess | Vice President, International | April 25, 2011 M | 18,941 | 0 | 0 | $0 |
| Robert Campbell | Vice President for Clinical | Jan. 25, 2010 M | 63,633 | 0 | 0 | $0 |
| David A Howe | VP of Human Resources | Feb. 26, 2009 A | · | 0 | 0 | $0 |
| Jason Ng | Vice President of Asian Operat | Feb. 26, 2009 A | · | 0 | 0 | $0 |
| Lars Boesgaard | Vice President of Finance | Feb. 26, 2009 A | · | 0 | 0 | $0 |
| Shawna Gvazdauskas | Senior Vice President of Sales | Feb. 26, 2009 A | 0 | 0 | 0 | $0 |
| John Garibotto | Vice President of Research | Feb. 26, 2009 A | · | 0 | 0 | $0 |
| Kevin Schmid | VP of Operations & Engineering | Feb. 26, 2009 A | 17,500 | 0 | 0 | $0 |
| William D Arthur III | V.P. of Business Development | Feb. 26, 2009 A | · | 0 | 0 | $0 |
| Andrew Suchoff | Chief Human Resources Officer | March 27, 2008 A | · | 0 | 0 | $0 |
| Jefferey Smith | Vice President of Marketing | March 12, 2008 A | · | 0 | 0 | $0 |
| Stephen Bubrick | Vice President of Customer | Aug. 9, 2007 A | · | 0 | 0 | $0 |
| Robert Luther Huffines | Director | Sept. 30, 2026 A | 2,627 | 0 | 0 | $0 |
| Jonathan Jay Mazelsky | Director | Sept. 30, 2026 A | 1,496 | 0 | 0 | $0 |
| Luciana Borio | Director | June 3, 2026 S | 4,329 | 0 | 1 | $-59,887 |
| Timothy C. Stonesifer | Director | June 3, 2026 P | 9,041 | 2 | 0 | $700,277 |
| Elizabeth H Weatherman | Director | June 3, 2026 P | 10,352 | 1 | 0 | $497,490 |
| Wayne A.I. Frederick | Director | May 20, 2026 A | 3,818 | 0 | 1 | $-542,510 |
| Jessica Hopfield | Director | May 20, 2026 A | 29,355 | 0 | 0 | $0 |
| Timothy J Scannell | Director | May 20, 2026 A | 33,024 | 0 | 0 | $0 |
| Michael R Minogue | Director | May 20, 2026 A | 2,438 | 1 | 0 | $499,847 |
| Shacey Petrovic | Director | Feb. 28, 2024 M | 2,567 | 0 | 0 | $0 |
| Corinne H Nevinny | Director | May 23, 2023 A | 6,010 | 0 | 0 | $0 |
| David A Lemoine | Director | Nov. 11, 2021 M | 10,756 | 0 | 0 | $0 |
| John A. Fallon | Director | May 21, 2021 M | 14,498 | 0 | 0 | $0 |
| MULLEN JAMES C | Director | May 16, 2018 A | 7,783 | 0 | 0 | $0 |
| Joseph S Zakrzewski | Director | May 17, 2017 A | 30,558 | 0 | 0 | $0 |
| Regina O Sommer | Director | May 17, 2017 A | 23,039 | 0 | 0 | $0 |
| Steven Sobieski | Director | May 13, 2015 A | 16,039 | 0 | 0 | $0 |
| Charles T Liamos | Director | April 1, 2015 M | 87,575 | 0 | 0 | $0 |
| Mark W Lortz | Director | June 3, 2013 A | 4,000 | 0 | 0 | $0 |
| Ross A Jaffe MD | Director | Feb. 22, 2012 S | 55,461 | 0 | 0 | $0 |
| Gary Eichhorn | Director | April 20, 2009 M | 70,749 | 0 | 0 | $0 |
| De Bord Alison Peyromaure | Director | May 8, 2008 A | 1,192,453 | 0 | 0 | $0 |
| ORBIMED ADVISORS LLC | Director | May 18, 2007 C | 1,568,841 | 0 | 0 | $0 |
| Jonathan Silverstein | Director | May 15, 2007 C | 1,568,841 | 0 | 0 | $0 |
| PRISM VENTURE PARTNERS III LP | 10% owner | Feb. 5, 2008 J | 0 | 0 | 0 | $0 |
| PRISM VENTURE PARTNERS III A LP | 10% owner | May 18, 2007 C | 18,324 | 0 | 0 | $0 |
| Sally Crawford | · | June 4, 2021 S | 20,306 | 0 | 0 | $0 |
| Gordon E Nye | · | May 18, 2007 C | 627,537 | 0 | 0 | $0 |
| Prism Investment Partners III LP | · | May 18, 2007 C | 627,537 | 0 | 0 | $0 |
| Prism Venture Partners III LLC | · | May 18, 2007 C | 627,537 | 0 | 0 | $0 |
| William M Seifert | · | May 18, 2007 C | 627,537 | 0 | 0 | $0 |
| John L Brooks | · | May 18, 2007 C | 627,537 | 0 | 0 | $0 |
| PEQUOT CAPITAL MANAGEMENT INC | · | May 18, 2007 C | 2,134,289 | 0 | 0 | $0 |
| Samuel D Colella | · | May 14, 2007 C | 89,372 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 81 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 2.10% | 5,226 NS | July 31, 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1.55% | 103,540 SH | Oct. 1, 2026 | Daily |
| IHI · iShares Trust | 1.40% | 331,132 SH | Sept. 11, 2026 | Daily |
| RPG · Invesco Exchange-Traded Fund Trust | 0.54% | 79,698 SH | Oct. 1, 2026 | Daily |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0.46% | 40,945 SH | Oct. 1, 2026 | Daily |
| PALC · Pacer Funds Trust | 0.45% | 5,703 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.31% | 22,170 SH | Sept. 11, 2026 | Daily |
| VBK · VANGUARD INDEX FUNDS | 0.29% | 917,724 SH | Aug. 19, 2026 | Daily |
| VFQY · VANGUARD WELLINGTON FUND | 0.28% | 8,788 SH | Aug. 19, 2026 | Daily |
| IWP · iShares Trust | 0.27% | 389,544 SH | Sept. 11, 2026 | Daily |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.25% | 30,632 NS | July 31, 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0.19% | 1,418,299 SH | Oct. 1, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.17% | 32,909 NS | July 31, 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.16% | 208,067 SH | Aug. 19, 2026 | Daily |
| IYH · iShares Trust | 0.15% | 40,413 SH | Sept. 11, 2026 | Daily |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0.14% | 67,413 NS | July 31, 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0.13% | 1,363 NS | July 31, 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0.13% | 1,588,917 SH | Aug. 19, 2026 | Daily |
| SMMD · iShares Trust | 0.13% | 36,947 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.12% | 25,127 SH | Oct. 1, 2026 | Daily |
| IXJ · iShares Trust | 0.12% | 36,601 SH | Sept. 11, 2026 | Daily |
| RECS · Columbia ETF Trust I | 0.10% | 35,821 NS | July 31, 2026 | N-PORT |
| ESML · iShares Trust | 0.10% | 19,841 SH | Sept. 11, 2026 | Daily |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.09% | 5,603 SH | Oct. 1, 2026 | Daily |
| WSML · iShares Trust | 0.08% | 4,139 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.08% | 70,592 NS | July 31, 2026 | N-PORT |
| IWR · iShares Trust | 0.07% | 284,401 SH | Sept. 11, 2026 | Daily |
| LRND · New York Life Investments ETF Trust | 0.06% | 1,564 NS | July 31, 2026 | N-PORT |
| CATH · Global X Funds | 0.05% | 4,302 NS | July 31, 2026 | N-PORT |
| XOEF · iShares Trust | 0.05% | 90 SH | Sept. 11, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.04% | 5,400 NS | July 31, 2026 | N-PORT |
| CHRI · Global X Funds | 0.04% | 17 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.03% | 1,128 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.03% | 92,460 NS | July 31, 2026 | N-PORT |
| HAPI · Harbor ETF Trust | 0.03% | 896 NS | July 31, 2026 | N-PORT |
| EGLE · Global X Funds | 0.03% | 4 NS | July 31, 2026 | N-PORT |
| VOOG · VANGUARD ADMIRAL FUNDS | 0.03% | 51,531 SH | Aug. 19, 2026 | Daily |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0.03% | 108,891 SH | Aug. 19, 2026 | Daily |
| GLBL · Pacer Funds Trust | 0.03% | 2 NS | July 31, 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.03% | 803 NS | July 31, 2026 | N-PORT |
| WRND · New York Life Investments ETF Trust | 0.03% | 18 NS | July 31, 2026 | N-PORT |
| IWF · iShares Trust | 0.03% | 259,928 SH | Sept. 11, 2026 | Daily |
| DSI · iShares Trust | 0.03% | 10,624 SH | Sept. 11, 2026 | Daily |
| TILT · FlexShares Trust | 0.03% | 3,476 NS | July 31, 2026 | N-PORT |
| IVW · iShares Trust | 0.03% | 147,682 SH | Sept. 11, 2026 | Daily |
| DCOR · Dimensional ETF Trust | 0.03% | 5,206 NS | July 31, 2026 | N-PORT |
| IUSG · iShares Trust | 0.03% | 61,820 SH | Sept. 11, 2026 | Daily |
| VOO · VANGUARD INDEX FUNDS | 0.02% | 1,797,121 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.02% | 11,373 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.02% | 15,641 SH | Aug. 19, 2026 | Daily |
| XYLD · Global X Funds | 0.02% | 3,708 NS | July 31, 2026 | N-PORT |
| XYLG · Global X Funds | 0.02% | 72 NS | July 31, 2026 | N-PORT |
| XCLR · Global X Funds | 0.02% | 4 NS | July 31, 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0.02% | 3,561 NS | July 31, 2026 | N-PORT |
| XRMI · Global X Funds | 0.02% | 53 NS | July 31, 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0.02% | 5,732 NS | July 31, 2026 | N-PORT |
| TOPC · iShares Trust | 0.02% | 42 SH | Sept. 11, 2026 | Daily |
| SPUU · Direxion Shares ETF Trust | 0.02% | 261 NS | July 31, 2026 | N-PORT |
| XVV · iShares Trust | 0.02% | 806 SH | Sept. 11, 2026 | Daily |
| QDPL · Pacer Funds Trust | 0.02% | 1,658 NS | July 31, 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0.01% | 11,043 SH | Oct. 1, 2026 | Daily |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.01% | 5,238 SH | Oct. 1, 2026 | Daily |
| IVV · iShares Trust | 0.01% | 873,214 SH | Sept. 11, 2026 | Daily |
| HCMT · Direxion Shares ETF Trust | 0.01% | 480 NS | July 31, 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0.01% | 408 SH | Oct. 1, 2026 | Daily |
| XTR · Global X Funds | 0.01% | 4 NS | July 31, 2026 | N-PORT |
| IYY · iShares Trust | 0.01% | 3,024 SH | Sept. 11, 2026 | Daily |
| IWB · iShares Trust | 0.01% | 48,747 SH | Sept. 11, 2026 | Daily |
| SPXL · Direxion Shares ETF Trust | 0.01% | 5,416 NS | July 31, 2026 | N-PORT |
| IWV · iShares Trust | 0.01% | 19,530 SH | Sept. 11, 2026 | Daily |
| ITOT · iShares Trust | 0.01% | 91,828 SH | Sept. 11, 2026 | Daily |
| PHDG · Invesco Actively Managed Exchange-T… | 0.01% | 53 SH | Oct. 1, 2026 | Daily |
| QVML · Invesco Exchange-Traded Fund Trust … | 0.01% | 1,399 SH | Oct. 1, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 2,199,830 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 59,978 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 5,816 SH | Aug. 19, 2026 | Daily |
| VOXP · Advisors Series Trust | 0.01% | 3 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 10,297 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 2,582 NS | July 31, 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0.00% | 23 NS | July 31, 2026 | N-PORT |
| ISCB · iShares Trust | · | 3,135 SH | Sept. 11, 2026 | Daily |
PODD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 33 analysts
BUY
Median target
$167.50
+27.2%
9 27.3%
Strong Buy
11 33.3%
Buy
13 39.4%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
22 analysts · 2026-09-27Mean target $171.91 +30.5%
← Below all targets
Current price $131.69
Low$144.00
Mean$171.91
High$275.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| IRTC | $5.73B | -127.7 | 26.2% | -6.0% | -34.8% | 70.6% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Latest News Recent headlines mentioning this company
Monday 6/8 Insider Buying Report: PODD, ADC
Nasdaq · 3 months, 3 weeks ago
Are Wall Street Analysts Bullish on Insulet Stock?
Yahoo Finance · 4 months ago
Why Goldman Sachs Trimmed Insulet Corporation (PODD) Price Target Despite Strong Q1 Results
Yahoo Finance · 4 months, 2 weeks ago
BTIG Maintains Buy Rating on Insulet (PODD)
Yahoo Finance · 5 months, 2 weeks ago
Analysts See 75% Upside on Insulet Corporation (PODD) Despite Weak Share Price Momentum
Yahoo Finance · 5 months, 3 weeks ago
Is Insulet Stock Underperforming the Dow?
Yahoo Finance · 6 months, 1 week ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 5, 2026